Who owns PDL BioPharma?

Key details on PDL BioPharma (Ticker: PDLI)

Who owns PDL BioPharma?

Is PDLI a good stock to own? Find out who bought PDL BioPharma, who sold PDL BioPharma (PDLI) stock, and who holds a large position in PDL BioPharma.

Fund Name Number of Shares Share Valuation As Of
BlackRock Fund Advisors 12.30M $94.86M Dec. 31, 2014
Renaissance Technologies 11.77M $90.75M Dec. 31, 2014
Vanguard 11.25M $86.77M Dec. 31, 2014
First Trust Advisors 8.69M $67.01M Dec. 31, 2014
Schroder Investment Management 8.68M $66.96M Dec. 31, 2014
Baupost 8.00M $49.60M Dec. 31, 2011
Acadian Asset Management 6.46M $45.45M March 31, 2015
FMR 6.37M $49.20M June 30, 2013
Advisors Asset Management 5.00M $38.55M Dec. 31, 2014
Bank of America Corporation 4.88M $37.59M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 4.56M $35.17M Dec. 31, 2014
STATE STREET CORPORATION 3.61M $27.82M Dec. 31, 2014
Inves 3.58M $27.61M Dec. 31, 2014
Gotham Asset Management 3.34M $28.22M Dec. 31, 2013
Wells Fargo & Company 3.22M $24.79M Dec. 31, 2014
AQR Capital Management 2.98M $22.97M June 30, 2013
MSDC Management 2.86M $18.94M June 30, 2012
OppenheimerFunds 2.82M $18.71M June 30, 2012
Hussman Econometrics Advisors 2.81M $21.69M June 30, 2013
Two Sigma Advisers 2.80M $21.52M Sept. 30, 2012
DIMENSIONAL FUND ADVISORS 2.69M $20.75M Dec. 31, 2014
NORTHERN TRUST 2.64M $20.33M Dec. 31, 2014
Robeco Institutional Asset Management B V 2.62M $20.19M Dec. 31, 2014

Who sold PDL BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Eagle Investment Management Dec. 31, 2010 3.55M $22.12M
Paulson & Co March 31, 2008 5.40M $57.16M